HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsuya Yamazaki Selected Research

Glucagon-Like Peptide 1 (GLP 1)

11/2022The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsuya Yamazaki Research Topics

Disease

13Type 2 Diabetes Mellitus (MODY)
11/2023 - 03/2003
3Albuminuria
08/2023 - 01/2020
3Body Weight (Weight, Body)
11/2022 - 08/2007
3Insulin Resistance
08/2009 - 11/2003
2Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 01/2020
2Chronic Renal Insufficiency
11/2022 - 01/2018
2Diabetes Mellitus
08/2006 - 08/2006
2Atherosclerosis
12/2005 - 06/2005
1Weight Loss (Weight Reduction)
11/2023
1COVID-19
08/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Stroke (Strokes)
01/2018
1Disease Progression
02/2017
1Obesity
02/2017
1Hyperplasia
01/2012
1Acth-Independent Macronodular Adrenal Hyperplasia
01/2012
1Overweight
12/2008
1Hypertension (High Blood Pressure)
08/2007
1Diabetes Complications
08/2006
1Inflammation (Inflammations)
12/2005
1Atherosclerotic Plaque (Atheroma)
06/2005

Drug/Important Bio-Agent (IBA)

4Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 08/2006
3Glucose (Dextrose)FDA LinkGeneric
11/2023 - 08/2007
3Insulin (Novolin)FDA Link
01/2022 - 08/2006
2LipidsIBA
08/2023 - 12/2008
2Hemoglobins (Hemoglobin)IBA
11/2022 - 01/2018
2CreatinineIBA
11/2022 - 01/2020
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2022 - 12/2008
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2022 - 02/2017
2AdipokinesIBA
08/2007 - 12/2005
2Interleukin-8 (Interleukin 8)IBA
12/2005 - 06/2005
1antineoplaston A10 (A 10)IBA
11/2023
1Glucagon-Like Peptide-1 ReceptorIBA
11/2022
1AlbuminsIBA
11/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2022
1dulaglutideIBA
11/2022
1BiguanidesIBA
02/2017
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2012
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2012
1Angiotensin IIIBA
08/2009
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2009
1Angiotensin II Type 1 Receptor BlockersIBA
08/2007
1HDL CholesterolIBA
08/2007
1Triglycerides (Triacylglycerol)IBA
08/2007
1Telmisartan (Micardis)FDA Link
08/2007
1LeptinIBA
08/2007
1PPAR gammaIBA
08/2007
1ChemokinesIBA
12/2005
1NF-kappa B (NF-kB)IBA
12/2005
1AdiponectinIBA
12/2005
1p38 Mitogen-Activated Protein KinasesIBA
06/2005
1CXC ChemokinesIBA
06/2005
1pitavastatin (itavastatin)FDA Link
06/2005
1C-Reactive ProteinIBA
06/2005
1LDL CholesterolIBA
06/2005
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
11/2003
1Advanced Glycation End ProductsIBA
03/2003

Therapy/Procedure

7Glycemic Control
08/2023 - 08/2006
3Therapeutics
01/2022 - 08/2006
2Drug Prescriptions
11/2023 - 01/2023
1Precision Medicine
01/2022
1Adrenalectomy
01/2012